Free-breathing Three-Dimensional Simultaneous Myocardial T1 and T2 Mapping Based on Multi-Parametric SAturation-recovery and Variable-flip-Angle.

Dongyue Si,Rui Guo,Lan Cheng,Xiangchuang Kong,Daniel A. Herzka,Haiyan Ding
DOI: https://doi.org/10.1016/j.jocmr.2024.101065
IF: 6.4
2024-01-01
Journal of Cardiovascular Magnetic Resonance
Abstract:Background: Quantitative myocardial tissue characterization with T1 and T2 parametric mapping can provide an accurate and complete assessment of tissue abnormalities across a broad range of cardiomyopathies. However, current clinical T1 and T2 mapping tools rely predominantly on two-dimensional (2D) breath-hold sequences. Clinical adoption of three-dimensional (3D) techniques is limited by long scan duration. The aim of this study is to develop and validate a time-efficient 3D free-breathing simultaneous T1 and T2 mapping sequence using multi-parametric SAturation-recovery and Variable-flip-Angle (mSAVA). Methods: mSAVA acquires four volumes for simultaneous whole-heart T1 and T2 mapping. We validated mSAVA using simulations, phantoms, and in-vivo experiments at 3T in 11 healthy subjects and 11 patients with diverse cardiomyopathies. T1 and T2 values by mSAVA were compared with modified Look-Locker inversion recovery (MOLLI) and gradient and spin echo (GraSE), respectively. The clinical performance of mSAVA was evaluated against late gadolinium enhancement (LGE) imaging in patients. Results: Phantom T1 and T2 by mSAVA showed a strong correlation to reference sequences (R2 = 0.98 and 0.99). In-vivo imaging with an imaging resolution of 1.5 x 1.5 x 8 mm3 could be achieved. Myocardial T1 and T2 of healthy subjects by mSAVA were 1310 +/- 46 and 44.6 +/- 2.0 ms, respectively, with T1 standard deviation higher than MOLLI (105 +/- 12 vs 60 +/- 16 ms) and T2 standard deviation lower than GraSE (4.5 +/- 0.8 vs 5.5 +/- 1.0 ms). mSAVA T1 and T2 maps presented consistent findings in patients undergoing LGE. Myocardial T1 and T2 of all patients by mSAVA were 1421 +/- 79 and 47.2 +/- 3.3 ms, respectively. Conclusion: mSAVA is a fast 3D technique promising for clinical whole-heart T1 and T2 mapping.
What problem does this paper attempt to address?